- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
EULAR immunization guidelines for children with autoimmune rheumatic disease
Netherlands: A recent article in Annals of the Rheumatic Diseases, reports updated EULAR/PRES recommendations for vaccination of pediatric patients with autoimmune inflammatory rheumatic diseases.
According to EULAR vaccine recommendations, pediatric patients who have received B-cell depleting medication within the last six months should get passive immunization when tetanus toxoid vaccination is necessary.
Recent findings supporting the safety of live-attenuated vaccines, as well as unique studies on the immunogenicity of immunizations in the era of biological disease-modifying antirheumatic medications in pediatric patients with autoimmune/inflammatory rheumatic disorders (pedAIIRD), warranted an update to the EULAR recommendations. These updated EULAR recommendations are intended for use by health care providers involved in the management and vaccination of pedAIIRD patients, such as pediatric rheumatologists, pediatricians, general practitioners, nurses, pharmacists, and primary healthcare professionals involved in the NIPs' implementation. These recommendations also attempt to educate patients and their families as part of informed/shared decision-making.
The EULAR standard operating procedures were used to create the recommendations. Two international specialist committees were organized to update immunization recommendations for AIIRD patients, both pediatric and adult. Following a systematic evaluation of the literature, specific recommendations for pediatric and adult patients were developed. Six overarching principles and 7 recommendations were developed for pedAIIRD and were given the level of evidence, strength of recommendation, and Task Force level of agreement.
The recommendations are as follows:
1. Non-live seasonal influenza vaccination should be strongly considered for pedAIIRD on immunosuppressive therapies
2. Pneumococcal vaccination with PCV10 or PCV13 is recommended in all non-vaccinated pedAIIRD
3. Tetanus vaccination should be administered in accordance with recommendations for the general population. In case of an indication for TT vaccination, passive immunization is recommended for patients receiving B-cell depleting therapy in the past 6 months
4. HPV vaccination should be strongly considered in non-vaccinated jSLE patients
5. (a) MMR booster vaccination can be administered to patients on MTX; (b) MMR booster can be considered in patients treated with low-dose glucocorticosteroids TNFi, anti-IL1, and anti-IL6 therapy
6. (a) VZV vaccination should be strongly considered in varicella vaccination/infection naïve patients on MTX (b) VZV vaccination can be considered in varicella vaccination/infection naïve patients on low-dose glucocorticosteroids, TNFi, anti-IL1, and anti-IL6 therapy
7. YF vaccination should be avoided in all immunosuppressed patients
Reference:
Jansen, M. H. A., Rondaan, C., Legger, G. E., Minden, K., Uziel, Y., Toplak, N., Maritsi, D., van den Berg, L., Berbers, G. A. M., Bruijning, P., Egert, Y., Normand, C., Bijl, M., N. M., & Heijstek, M. W. (2022). EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. In Annals of the Rheumatic Diseases (p. annrheumdis-2022-222574). BMJ. https://doi.org/10.1136/annrheumdis-2022-222574
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751